Biodexa Pharmaceuticals
(NASDAQ:BDRX)
$0.9705
-0.0097[-0.99%]
At close: May 30
$0.9705
0[0.00%]
After Hours: 7:57PM EDT

Biodexa Pharmaceuticals Stock (NASDAQ:BDRX), Earnings Estimates, EPS, and Revenue

Biodexa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Sep 29
EPS
$-19.860
Quarterly Revenue
$370K
Annual Revenue
(as of Dec 31)
$381K

Analyze the earnings history of Biodexa Pharmaceuticals using advanced sorting and filters.

Get Alert
BDRX
Biodexa Pharmaceuticals
-$9.59$865.09K06/11/2024Get Alert
BDRX
Biodexa Pharmaceuticals
-$0.20-$19.86$608.39K$369.97K09/29/2023Get Alert
BDRX
Biodexa Pharmaceuticals
-$9.59$865.09K05/22/2023Get Alert
BDRX
Biodexa Pharmaceuticals
-$0.20$608.39K09/14/2022Get Alert

FAQ

Q

When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?

A

Biodexa Pharmaceuticals (BDRX) is scheduled to report earnings on June 11, 2024. The last reported earnings were for reported on September 29, 2023 for H1.

Q

What were the latest earnings per share (EPS) for Biodexa Pharmaceuticals (NASDAQ:BDRX)?

A

The Actual EPS was $-19.86, which missed the estimate of $0.00.

Q

What were Biodexa Pharmaceuticals’s (NASDAQ:BDRX) revenues?

A

The Actual Revenue was $370K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch